Skip to main content

Table 3 Test Characteristics of Selected HC Thresholds for Diagnosis of Children with IEC or MGCM Requiring Intervention

From: The test characteristics of head circumference measurements for pathology associated with head enlargement: a retrospective cohort study

A

B

C

D

E

G

H

I

K

L

M

N

Threshold

Number in source population

Number diagnosed with IEC or MGCM requiring intervention

Number above threshold

Number above threshold with IEC or MGCM requiring intervention

Sensitivity

E/C

Specificity

(B-C-(D-E))/(B-C)

Positive predictive value

E/D

Likelihood ratio positive

G/(1-H)

Likelihood ratio negative

(1-G)/H

Number Needed to Screen

B/E

Number Needed to Test

D/E

Above CDC 95th

74,428

24

12,325

11

46%

83%

0.1%

2.8

0.6

6,766

1,120

Above WHO 95th

74,428

24

18,528

14

58%

75%

0.1%

2.3

0.6

5,316

1,323

Above PCN 95th

74,428

24

7,694

9

38%

90%

0.1%

3.6

0.7

8,270

855

Above CDC 97th

74,428

24

8,373

9

38%

89%

0.1%

3.3

0.7

8,270

930

Above WHO 97th

74,428

24

13,275

12

50%

82%

0.1%

2.8

0.6

6,202

1,106

Above PCN 97th

74,428

24

4,532

7

29%

94%

0.2%

4.8

0.8

10,633

647

Above CDC 99.6th

74,428

24

2,030

6

25%

97%

0.3%

9.2

0.8

12,405

338

Above WHO 99.6th

74,428

24

3,438

6

25%

95%

0.2%

5.4

0.8

12,405

573

Above PCN 99.6th

74,428

24

711

5

21%

99%

0.7%

22.0

0.8

14,886

142

Crossed 2 IMPL-CDC

64,015

21

29,206

18

78%

54%

0.1%

1.7

0.4

3,566

1,623

Crossed 2 IMPL-WHO

64,015

21

22,462

10

43%

65%

< 0.1%

1.2

0.9

6,402

2,246

Crossed 2 IMPL-PCN

64,015

21

13,831

9

39%

78%

0.1%

1.8

0.8

7,113

1,537

Crossed 4 IMPL-CDC

64,015

21

5,727

4

17%

91%

< 0.1%

1.9

0.9

16,004

1,432

Crossed 4 IMPL-WHO

64,015

21

4,372

2

9%

93%

0.1%

1.3

1.0

32,008

2,186

Crossed 4 IMPL-PCN

64,015

21

1,703

2

9%

97%

0.2%

3.3

0.9

32,008

852

  1. IEC (intracranial expansive condition); MGCM (metabolic or genetic condition associated with macrocephaly); CDC (Centers for Disease Control head circumference growth curves); WHO (World Health Organization head circumference growth curves); PCN (primary care network head circumference growth curves); IMPL (increasing multiple percentile lines). The negative predictive value (C-(D-E))/(C-D) was 99.9% for all thresholds. No subjects with the outcome crossed 6 IMPL, so rows for that outcome were not included.